Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – In patients with newly diagnosed type 1 diabetes, high-dose immune ablation followed by autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) induces significant and…
NEW YORK (Reuters Health) – New research suggests that marijuana use may increase the risk of testicular germ cell tumors (TGCTs), primarily nonseminoma types. According to the report…
NEW YORK (Reuters Health) – Women with synchronous primary ovarian and endometrial cancers have better survival rates than women with single ovarian cancers do, according to a report…
ORLANDO (Reuters Health) – New findings, announced here during the annual meeting of the American College of Cardiology, show that rosuvastatin significantly reduces the risk of venous thromboembolism…
NEW YORK (Reuters Health) – Use of a high cut-off dialyzer can help patients with acute renal failure secondary to multiple myeloma become dialysis free, the results of…
NEW YORK (Reuters Health) For patients with epidermal growth factor (EGF) receptor-positive colorectal cancer and unresectable metastases, adding cetuximab to first-line treatment with irinotecan, fluorouracil, and leucovorin (FOLFIRI)…
NEW YORK (Reuters Health) – Annual ovarian cancer screening with transvaginal ultrasonography and CA 125 usually misses early-stage disease while it often results in unneeded surgeries, according to…
NEW YORK (Reuters Health) – For carefully selected patients with stage II to IVa laryngeal cancer, platinum-based chemotherapy may be sufficient to provide pathological complete response, results of…
NEW YORK (Reuters Health) – Consolidation therapy with low-dose thalidomide and prednisolone can improve survival in patients with multiple myeloma who have undergone autologous stem-cell transplantation (ASCT), according…
Jason Sheehan, MD, PhD, Co-Director Riverside – UVA Gamma Knife, University of Virginia Health System, discusses gamma knife surgery for the treatment of malignant brain tumors, a procedure…
